CLINICAL APPLICABILITY OF CURRENT PHARMACOKINETIC MODELS - SPLANCHNIC ELIMINATION OF 5-FLUOROURACIL IN CANCER-PATIENTS

被引:15
作者
ROBINSON, PJ
BASS, L
POND, SM
ROBERTS, MS
WAGNER, JG
机构
[1] UNIV QUEENSLAND,DEPT MATH,ST LUCIA,QLD 4067,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT MATH,BRISBANE,QLD 4000,AUSTRALIA
[3] UNIV QUEENSLAND,DEPT MED,BRISBANE,QLD 4000,AUSTRALIA
[4] UNIV OTAGO,SCH PHARM,DUNEDIN,NEW ZEALAND
[5] UNIV MICHIGAN,SCH PHARM,DEPT PHARMACOL,ANN ARBOR,MI 48109
[6] UNIV MICHIGAN,UPJOHN CTR CLIN PHARMACOL,ANN ARBOR,MI 48109
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1988年 / 16卷 / 03期
关键词
D O I
10.1007/BF01062135
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:229 / 249
页数:21
相关论文
共 25 条
[21]   HEPATIC ELIMINATION - DISPERSION MODEL [J].
ROBERTS, MS ;
ROWLAND, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (05) :585-587
[22]  
ROBINSON PJ, 1979, THESIS U QUEENSLAND
[23]   CLEARANCE CONCEPTS IN PHARMACOKINETICS [J].
ROWLAND, M ;
BENET, LZ ;
GRAHAM, GG .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02) :123-136
[24]  
SPEYER JL, 1981, CANCER RES, V41, P1916
[25]  
WAGNER JG, 1986, CANCER RES, V46, P1499